Table 4.
Three-level model | Odds ratio (95% CI) | P value |
---|---|---|
Patient factors |
|
|
Surgical admission |
1.09 (0.68, 1.75) |
0.718 |
APACHE II score (10-point increase) |
1.49 (1.17, 1.89) |
0.001 |
Cancera |
3.22 (1.81, 5.72) |
<0.001 |
History of venous thromboembolism |
3.94 (1.46, 10.66) |
0.007 |
Body mass index (10-point increase) |
1.32 (1.05, 1.65) |
0.018 |
Daily factorsb |
|
|
Any dialysis |
0.79 (0.45, 1.40) |
0.422 |
Invasive mechanical ventilation |
1.83 (1.32, 2.52) |
<0.001 |
Vasopressors or inotropes |
1.26 (0.90, 1.78) |
0.184 |
Site factors |
|
|
Dedicated thrombosis consulting service |
1.91 (0.95, 3.86) |
0.069 |
Preprinted orders including thromboprophylaxis | 1.00 (0.51, 1.98) | 0.989 |
Results of the multilevel logistic regression model examining determinants of guideline concordance (use of any pharmacological thromboprophylaxis unless contraindications exist). The three levels are center, patient, and ICU-day. There were 10,540 patient-days (10,154 with concordance, 386 without), n = 1,533 patients. Body mass index values were missing for 402 of the 1,935 patients enrolled in the study. These patients were therefore excluded from the regression analysis. APACHE, Acute Physiology and Chronic Health Evaluation; CI, confidence interval. aCancer refers to lymphoma, metastatic cancer, leukemia, multiple myeloma, active solid malignancy, or history of solid malignancy. bDaily factors reflect exposure in the preceding 3 days.